ICD-10-CM code · FY2027
E85.89 Other amyloidosis
BillableValid for claims as a specific diagnosis code
About E85.89
EvidencePulse™by 2 Minute Medicine®
Go deeper into amyloidosis.
Ask about the latest evidence, the landmark trials or what guidelines recommend, with every study cited. No ads, no sponsored answers.
Coding notes for E85.89
No notes of its own; the notes below apply from the codes above it.
Also applies, from E85 Amyloidosis
Excludes2 Not part of this condition, but a patient can have both: report both codes when both apply.
- Alzheimer's disease (G30.0-)
Block E70-E88 notes (apply to every code in it)
Excludes1 Not coded here: never report these together with this code (use the code given instead).
Excludes2 Not part of this condition, but a patient can have both: report both codes when both apply.
- Ehlers-Danlos syndromes (Q79.6-)
Chapter 4 notes (apply to every code in it)
Note
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Related codes in E85.8
Latest research on amyloidosis
- Vutrisiran reduces mortality in transthyretin amyloidosis with cardiomyopathy
- Patisiran prevents functional decline in patients with cardiac amyloidosis
- #VisualAbstract: Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis
- Daratumumab therapy addition improved response in systemic immunoglobulin light-chain amyloidosis
- Patisiran therapy reduces ventricular myocardial strain in hereditary transthyretin amyloidosis
2MM+
Read the research behind every diagnosis
2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.
See 2MM+ plansICD-10-CM FY2027 code set, as published by the CDC National Center for Health Statistics (NCHS) and CMS, effective October 1, 2026 to September 30, 2027. Codes, titles and notes are shown as published. Check payer rules and the official guidelines before billing. This page is not medical advice.
Get the app